# A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

> **NCT02035111** · PHASE4 · COMPLETED · sponsor: **Jiangsu Kanion Pharmaceutical Co., Ltd** · enrollment: 947 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Tianshu capsule
- **DRUG:** Sugar pill

## Key facts

- **NCT ID:** NCT02035111
- **Lead sponsor:** Jiangsu Kanion Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-11
- **Target enrollment:** 947 (ACTUAL)
- **Last updated:** 2016-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02035111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02035111, "A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02035111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*